New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
06:59 EDTARIAARIAD's Ponatinib progressing well in Europe, says RBC Capital
RBC Capital's checks indicate ARIAD's Ponatinib EU CHMP recommendation could come as early as the 3rd week of March, putting EU approval at the end of Q2, ahead of guidance for Q3,and that France has used the drug under temporary authorization and has generated $1M + in differed revenues. Shares are Outperform rated.
News For ARIA From The Last 14 Days
Check below for free stories on ARIA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
12:37 EDTARIASarissa says ARIAD denied 'poison pill' waiver request
Subscribe for More Information
August 25, 2014
12:37 EDTARIAARIAD ICLUSIG prescriptions encouraging, says BMO Capital
Subscribe for More Information
10:40 EDTARIABiotechs rise after InterMune acquired by Roche
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use